One vs two weeks of breast radiation after lumpectomy
Part of Cancer, Skin clinical trials.
This trial compares a shorter, one-week course of radiation to the standard two-week course after a lumpectomy for early-stage breast cancer. The goal is to see if one week is just as effective and safe, making treatment more convenient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who had a partial mastectomy (lumpectomy) for breast cancer.
- Your cancer was stage 1 or 2 (or DCIS) and all the cancer was removed with clear margins.
- You have not had radiation therapy to the same breast before.
- You are not currently being treated for a severe autoimmune disease.
- Your last breast surgery was within 90 days (or within 60 days of finishing chemotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of radiation after breast surgery in people with high-risk, node-positive breast cancer. The goal is to see whether giving radiation in 1 week or 2 weeks works well and is safe after standard treatments.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial compares two different schedules of radiation therapy after breast cancer surgery to see if a shorter course is as effective. It may help reduce the number of hospital visits for patients who have had breast-conserving surgery or a mastectomy.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests whether a shorter course of radiation therapy (called hypofractionated) after lumpectomy is safe and works well for early breast cancer. It aims to make treatment more convenient while keeping the same benefits.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.